NCT03854344View on ClinicalTrials.gov

Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

PHASE4RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pain, PostoperativeBurns
Interventions
DRUG

Lidocaine Hydrochloride

Injected subcutaneously for skin graft harvesting

DRUG

Liposomal bupivacaine

Injected subcutaneously for skin graft harvesting

DRUG

Bupivacaine Hydrochloride

Used for regional nerve block for skin graft harvesting

Trial Locations (1)

66160

RECRUITING

The University of Kansas Health System, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER